Connection
Shannon Carpenter to Antibodies, Monoclonal, Humanized
This is a "connection" page, showing publications Shannon Carpenter has written about Antibodies, Monoclonal, Humanized.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.214 |
|
|
|
-
Escobar M, Dunn A, Quon D, Trzaskoma B, Lee L, Ko RH, Carpenter SL. A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures. Haemophilia. 2022 07; 28(4):e105-e108.
Score: 0.214